Search research articles
Contact Us
Filters
Showing results (61-70 of 67) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 67 results.
Gynecologic Oncology
|
February 27, 2004
Cultures of ovarian surface epithelium from women with and without a hereditary predisposition to develop female adnexal carcinoma
Jurgen M J Piek, Josephine C Dorsman, Avi Shvarts, et al.
The Lancet. Oncology
|
January 27, 2009
Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial
Peter Kenemans, Nigel J Bundred, Jean-Michel Foidart, et al.
American Journal of Obstetrics and Gynecology
|
November 25, 2003
Effects of low-dose oral and transdermal estrogen replacement therapy on hemostatic factors in healthy postmenopausal women: a randomized placebo-controlled study
Marinka S Post, Marius J van der Mooren, W Marchien van Baal, et al.
Breast Cancer Research : BCR
|
January 19, 2012
Tibolone increases bone mineral density but also relapse in breast cancer survivors: LIBERATE trial bone substudy
Nigel J Bundred, Peter Kenemans, Cheng Har Yip, et al.
International Journal of Cancer
|
April 15, 2006
Low prevalence of (pre) malignant lesions in the breast and high prevalence in the ovary and Fallopian tube in women at hereditary high risk of breast and ovarian cancer
Brenda B J Hermsen, Paul J van Diest, Johannes Berkhof, et al.
The New England Journal of Medicine
|
August 16, 2008
The effects of tibolone in older postmenopausal women
Steven R Cummings, Bruce Ettinger, Pierre D Delmas, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
|
September 23, 2014
ISGE statement on oral emergency contraception
Anna Glasier, Kristina Gemzell-Danielsson, Philippe Bouchard, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 67) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 67 results.
Gynecologic Oncology
|
February 27, 2004
Cultures of ovarian surface epithelium from women with and without a hereditary predisposition to develop female adnexal carcinoma
Jurgen M J Piek, Josephine C Dorsman, Avi Shvarts, et al.
The Lancet. Oncology
|
January 27, 2009
Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial
Peter Kenemans, Nigel J Bundred, Jean-Michel Foidart, et al.
American Journal of Obstetrics and Gynecology
|
November 25, 2003
Effects of low-dose oral and transdermal estrogen replacement therapy on hemostatic factors in healthy postmenopausal women: a randomized placebo-controlled study
Marinka S Post, Marius J van der Mooren, W Marchien van Baal, et al.
Breast Cancer Research : BCR
|
January 19, 2012
Tibolone increases bone mineral density but also relapse in breast cancer survivors: LIBERATE trial bone substudy
Nigel J Bundred, Peter Kenemans, Cheng Har Yip, et al.
International Journal of Cancer
|
April 15, 2006
Low prevalence of (pre) malignant lesions in the breast and high prevalence in the ovary and Fallopian tube in women at hereditary high risk of breast and ovarian cancer
Brenda B J Hermsen, Paul J van Diest, Johannes Berkhof, et al.
The New England Journal of Medicine
|
August 16, 2008
The effects of tibolone in older postmenopausal women
Steven R Cummings, Bruce Ettinger, Pierre D Delmas, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
|
September 23, 2014
ISGE statement on oral emergency contraception
Anna Glasier, Kristina Gemzell-Danielsson, Philippe Bouchard, et al.
Page
of 7